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Abstract
Background: Sitosterolemia is a recessively inherited disorder in humans that is associated with
premature atherosclerotic disease. Mutations in ABCG5 or ABCG8, comprising the sitosterolemia
locus, STSL, are now known to cause this disease. Three in-bred strains of rats, WKY, SHR and
SHRSP, are known to be sitosterolemic, hypertensive and they carry a missense 'mutation' in a
conserved residue of Abcg5, Gly583Cys. Since these rat strains are also know to carry mutations
at other genetic loci and the extent of phytosterolemia is only moderate, it is important to verify
that the mutations in Abcg5 are causative for phytosterolemia and whether they contribute to
hypertension.
Methods:  To investigate whether the missense change in Abcg5 is responsible for the
sitosterolemia we performed a segregation analysis in 103 F2 rats from a SHR × SD cross.
Additionally, we measured tail-cuff blood pressure and measured intestinal lipid transport to
identify possible mechanisms whereby this mutation causes sitosterolemia.
Results: Segregation analysis showed that the inheritance of the Gly583Cys mutation Abcg5
segregated with elevated plant sterols and this pattern was recessive, proving that this genetic
change is responsible for the sitosterolemia in these rat strains. Tail-cuff monitoring of blood
pressure in conscious animals showed no significant differences between wild-type, heterozygous
and homozygous mutant F2 rats, suggesting that this alteration may not be a significant determinant
of hypertension in these rats on a chow diet.
Conclusion: This study shows that the previously identified Gly583Cys change in Abcg5 in three
hypertension-susceptible rats is responsible for the sitosterolemia, but may not be a major
determinant of blood pressure in these rats.
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Background
Sitosterolemia is an autosomal recessive disease, charac-
terized by significantly increased plasma levels of plant
sterols (such as sitosterol, campesterol), and is associated
with premature atherosclerotic disease [1]. This disease
has been mapped to a single locus, STSL, on human chro-
mosome 2p21 [2,3]. Mutations in both alleles of one of
two genes, ABCG5 or ABCG8, that comprise this locus, are
now known to cause this disease [4-6]. No phytostero-
lemic patient with a single mutant ABCG5 allele and a
mutant ABCG8 allele has been reported, suggesting these
genes are not only linked physically, but their protein
products may act as obligate heterodimers. ABCG5 and
ABCG8 encode for sterolin-1 and sterolin-2 respectively.
These genes are expressed in the liver, gall bladder and
intestine and are implicated in determining biliary sterol
excretion and selectivity of sterol absorption at the apical
surfaces of the enterocytes [7-12]. Studies in mice defi-
cient for Abcg5 or Abcg8, as well as one that over-
expresses these genes, have confirmed that sterolins may
be the major determinants of biliary sterol secretion [13-
18]. Their role in preventing non-cholesterol sterol
absorption in the intestine remains to be clarified.
Prior to the identification of the gene defects in sitostero-
lemia, the presence of sitosterolemia had been reported in
the spontaneously hypertensive rat (SHR), although the
molecular basis of this phenotype had not been investi-
gated [19-25]. Sitosterolemia, hemolysis (a feature also
present in human sitosterolemia) and an increased mor-
tality when fed certain plant oils (enriched in plant ster-
ols) have also been reported in SHR and SHRSP rats [20].
The SHR, SHRSP and their 'parental' strain, WKY rats have
now been shown to carry a homozygous G1757T altera-
tion in Abcg5 that results in a Gly583Cys change [26,27].
All of these rat strains are also sitosterolemic. However, all
of these rats are highly in-bred and have been maintained
by brother-sister matings [28]. These rats are likely to carry
a number of mutated genes as part of their genetic burden.
At least 4 'mutated' loci are known to be part of this bur-
den; Cd36 [29], Srebp-1 [30], Kat-2 [31] and Abcg5
[26,27]. Although the Gly583Cys affects a highly con-
served residue (conserved from Fugu to Man) [27], given
the known genetic burden in the SHR line, it remains pos-
sible that genetic alterations at other loci may be respon-
sible for the sitosterolemia. Support for this possibility
has recently come from a quantitative trait genetic map-
ping study for sitosterolemia involving two mouse strains,
C57Bl/6J and CASA/Rk [32,33]. Although the plasma
sitosterol level was genetically determined in these mouse
strains, loci that accounted for this did not map to the
murine  STSL  and thus other unidentified genes were
hypothesized to be involved [32,33].
We report here genetic and biochemical analyses of F2 rats
from a SHR × SD cross to test the hypothesis that the
Gly583Cys is responsible for the sitosterolemia. In addi-
tion, since hypertension is a known phenotype of the SHR
and since feeding diets rich in plant sterols seem to
decrease their life-span, we also investigated the possibil-
ity that this genetic change may also be important in play-
ing a role in hypertension.
Results
Segregation analyses of plasma cholesterol and plant 
sterols
To ensure there were no significant differences in growth
curves of the F2 animals by Abcg5 genotype, body weights
were measured serially and analyzed only after the geno-
types had been determined at the end of the 14 weeks
(Fig. 1). The genetic status at the STSL locus did not affect
growth parameters. Blood from 14-week old F2 animals
fed a chow diet was obtained after a 4 h fast and analyzed
for cholesterol, as well as plant sterols, determined by GC
analyses (see Methods). All sterol analyses were per-
formed independent of the genotype analyses. Fig. 2
shows the distribution of cholesterol (Fig 2A) and sito-
sterol (Fig 2B) in these animals. The distribution of cho-
lesterol was slightly skewed to the right, with a mean
cholesterol value of 59.5 mg/dl. The distribution of sito-
sterol was significantly right-skewed and suggested a bi-
modal pattern.
All animals were genotyped for the Abcg5 G1757T muta-
tion and grouped according to wild-type (WT), hetero-
zygous (HET) or homozygous mutant (HMZ) and their
plasma cholesterol (Fig. 3A) and sitosterol (Fig. 3B) values
plotted as individual values. Two investigators, each
blinded to each other's results performed the genotype
and sterol analyses separately. There were no significant
differences in plasma cholesterol values between any of
the genotypes (Fig. 3A). All but two data points (high-
lighted in Fig. 3B) showed a robust segregation of
homozygous inheritance of mutant alleles with elevated
plant sterol levels. The two exceptions were a WT rat with
an elevated plant sterol and a homozygous mutant rat that
exhibited low levels of sitosterol. Unfortunately, the plant
sterol levels were made available only after all of these ani-
mals had been sacrificed and it was not possible to re-
sample the blood to re-confirm the plasma values,
although archived DNA allowed us to confirm the geno-
types. Thus an error in sample mis-identification could
not be confirmed.
Plasma levels of campesterol, campestanol and total plant
sterols were also significantly elevated in the HMZ ani-
mals compared to WT and HET animals (Fig. 4A, B and
D), with non-significant increases in sitostanol (Fig. 4C).
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heterozygous animals had plasma sitosterol, campesterol
and total plant sterol values as high as those from rats
homozygous for the Abcg5 mutation. All of these meas-
urements were obtained on animals fed a chow diet and a
diet challenge to distinguish between these various geno-
types was not performed.
Intestinal absorption of lipid
To identify possible mechanisms for the elevated plant
sterols, we performed lymph duct cannulation in WT,
HET and HMZ male rats and monitored absorption of
cholesterol, and fat. Although we attempted lymph duct
cannulation in 30 animals, we obtained data in only 3
WT, 4 HET and 4 HMZ animals due to either a high mor-
tality or unacceptable lymph flow. Lymphatic flow rates in
successfully cannulated rats are shown in Fig. 5A. There
were no differences by genotype. Following a bolus deliv-
ery of radioactive cholesterol and triolein (see Methods),
no differences were observed between WT, HET or HMZ
rats for recovery of radioactivity in the lymph for either
triglyceride or cholesterol (Fig. 5A and B), suggesting that
these pathways were relatively normal. Lymphatic recov-
ery for absorption of sitosterol was not performed.
Biliary secretion of plasma cholesterol and plant sterols
To further elucidate the mechanism by which plant sterols
were accumulating in the Abcg5 mutant animals, we col-
lected and analyzed bile for sterols in 24-week old after
they had been fed a defined diet containing 300 mg/kg of
sitosterol (Fig. 6). There were no differences in the
amounts of cholesterol present in the bile from any of the
three genotypes (Fig 6A). However, significantly more
sitosterol was present in the bile of mutant rats compared
to either HET or WT rats (Fig 6B), suggesting that the
Growth Curves of F2 mice Figure 1
Growth Curves of F2 mice. The body weights of male (top set of lines) and female (bottom set of lines) F2 rats were mon-
itored with time. At 17 weeks, most of the male F2 animals were sacrificed, or were used to determine intestinal absorption 
(see Fig. 5). At 17 weeks, female F2 rats were placed on a more defined plant sterol diet and their drinking water substituted 
with 1% NaCl. No differences in body weight gains between any of the Abcg5 genotypes (wild-type, WT; heterozygous, HET 
and homozygous mutant, HMZ) were observed.
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excretory pathways are functional and not affected by this
mutation. Thus the increased plasma plant sterol levels
were reflected by the increased biliary secretion.
Effect of Abcg5 mutation on blood pressure
We used the tail-cuff measurement technique to monitor
systolic blood pressure in these rats on a chow diet, with
Sterol distribution in F2 rats at 14 weeks age Figure 2
Sterol distribution in F2 rats at 14 weeks age. Blood for sterol analyses by GC was drawn at 14 weeks age (see Meth-
ods). The frequency distribution of cholesterol, in deciles, was almost Gaussian, with a slight right skew (panel A). However, 
plasma sitosterol, expressed in 0.5 mg/dl increments, was significantly right skewed (panel B).
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time. All blood pressure measurements were accumulated
independent of the genotype results and only after all
blood pressure measurements had been accumulated
were the data analyzed by genotype (Fig. 7). In male (Fig
7A) or female (Fig 7B) mice on a chow diet, no differences
up to 16 weeks of age were noted. For comparison, male
SD rats had a mean systolic blood pressure of 128 mm Hg
and the value for SHR was 197 mm Hg.
In a separate study, female mice were switched to a
defined diet (containing 300 mg/kg plant) and had 1%
NaCl added to the drinking water and blood pressures
recorded for a further 5 weeks (Fig 7B, see bar). No differ-
ences in blood pressure were seen in any of the genotypes,
nor was there a progressive increase in overall blood pres-
sures recorded.
Discussion
Sitosterolemia is a rare autosomal recessive inherited met-
abolic disorder of man that results in the accumulation on
non-cholesterol sterols from the diet and is associated
with premature coronary heart disease, hemolytic anemia
and the formation of tendon and tuberous xanthomas [1].
The genetic defect(s) has now been mapped and
identified. Mutations in one of two genes organized in
tandem on human chromosome 2p21, ABCG5 or
ABCG8, cause this defect [34]. As part of the literature sur-
vey, we observed that elevations of plant sterols had been
reported in rats commonly used for hypertension and
stroke research, WKY, SHR and SHRSP [19-25]. Interest-
ingly, a number of studies had reported previously that
alteration in diets not only increased the hemolysis asso-
ciated with the presence of sitosterol in these rats, but had
a dramatic effect on life-expectancy as well as led to an
increase in hypertension [20,24]. Thus SHRSP rats fed
canola or soy-bean oils supplemented with phytosterols
led to a significantly shortened life-span relative to oils
low in plant sterols [19]. Other investigators have
reported the association of hypertension in these rat
strains when fed diets supplemented with sitosterol, sug-
gesting that hypertension may be modified by plant sterol
accumulation [22].
Examination of SHR, SHRSP and WKY rats showed that
these rats carried a homozygous missense in Abcg5,
Gly583Cys, affecting a residue that shows conservation
from Fugu to Man, despite the relative conservative
change with respect to the amino acids involved [26,27].
At present, there are no control strains for WKY, SHR or
SHRSP, since these strains have been maintained by
brother-sister matings for >80 generations. Additionally,
some of these strains have been maintained by different
investigators for several generations raising the possibility
that there may also be sub-strain variations between
Plasma sterols as a function of Abcg5 genotypes Figure 3
Plasma sterols as a function of Abcg5 genotypes. Cholesterol (panel A) and sitosterol (panel B) were segregated in all 
F2 animals by Abcg5 Gly583Cys. While there were no differences between cholesterol values between any of the genotypes, 
F2 rats who were homozygous for Cys583 (HMZ) showed significantly higher plasma sitosterol values (*, P < 0.05, mean 5.12 
± 0.25 mg/dl) compared to either heterozygous animals (HET, mean 2.68 ± 0.16 mg/dl) or wild-type (WT, mean 2.25 ± 0.20 
mg/dl). These data were analyzed with the inclusion of two 'outliers' (arrows), one in the WT group and one in the HMZ 
group, where re-analyses to confirm these values were not possible (see Text).
*
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different colonies. Although these strains have been used
extensively in genetic analyses of hypertension and a
number of loci mapped for this trait, none of these loci
map to the rat STSL locus on chromosome 6 [35]. In a lit-
erature search of genetic changes reported for these
strains, we were able to compile at least 3 other loci that
are mutated in the SHR strain (Cd36, Srebp-1 and Kat-2),
suggesting the possibility that the missense 'mutation'
identified in Abcg5 is not causative for sitosterolemia
(which is also moderate in comparison to levels seen in
patients with sitosterolemia who have levels frequently
>15 mg/dl), but associated as a result of the in-breeding
[29-31]. Additionally, a murine QTL study of plasma sito-
sterol levels showed that plant sterol levels were strongly
influenced genetically, but mapping studies showed that
this trait did not map to the murine STSL on chromosome
17 [33], raising the possibility that other loci/factors may
be involved. Finally, in a study involving the GH and Nor-
wegian Brown rat strains (neither of which are sitostero-
lemic), a QTL for hypertension was mapped to the region
encompassing the rat STSL. However, we sequenced the
rat STSL in both of these strains and did not identify any
differences, suggesting that variations at the STSL in the
rat may not be contributing to the hypertension [27]. We
therefore undertook this study to test the hypothesis that
the Gly583Cys was causative for sitosterolemia. We also
measured blood pressure to test the hypothesis that this
mutation was responsible for contributing to an elevation
in blood pressure in these affected strains.
Segregation analyses in a large F2 population (SHR × SD)
showed that homozygosity for Gly583Cys segregated with
elevated plasma plant sterol levels in all but two animals.
Of these latter animals, we could not verify that the
Segregation analyses of other plant sterols by genotype Figure 4
Segregation analyses of other plant sterols by genotype.  Segregation of campesterol (panel A), its metabolite, campes-
tanol (panel B), the metabolite of sitosterol, sitostanol (panel C), or total plant sterols (panel D) are as shown. In all cases, 
except for sitostanol, the homozygous F2 rats had significantly elevated levels (* P < 0.05).
*
*
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samples had been inadvertently mis-labeled, as we could
not repeat plasma analysis as the animals had been sacri-
ficed before the plant sterol analyses were available. If we
exclude these animals, all animals that are homozygous
for the Gly583Cys are also sitosterolemic on a rodent
chow diet, proving that this genetic change was responsi-
ble for the elevation in dietary non-cholesterol sterols.
We also tracked blood pressures, using tail cuff measure-
ments, in all weaned animals for up to 4 months. No dif-
ferences in blood pressures by genotype were observed in
these F2 animals. In a sub-study, at ~ 4 months, female
rats were switched to a more defined diet that had a higher
level of plant sterols (300 mg/kg compared to ~ 130 mg/
kg in most rodent chow preparations). This was done as
normal rodent chow is known to lead to variable sterol
absorption. Additionally, the rats were given drinking
water supplemented with 1% NaCl to increase any mani-
festation of hypertension. Despite these interventions,
rats homozygous for the Gly583Cys change did not show
any significant increases in hypertension, relative to wild-
type or heterozygous animals. Thus, in our study, we
could not demonstrate an increase in blood pressures,
contrary to other published data. There are several expla-
nations for this discrepant finding. Firstly, our animals are
F2 animals and since a number of loci are implicated in
Intestinal lipid absorption in F2 rats Figure 5
Intestinal lipid absorption in F2 rats. Male F2 rats had their lymph ducts cannulated as described (see Methods) and had 
lymph flow quantitiated to ensure adequate and stable flow (panel A). Labeled triolein (panel B) or cholesterol (panel C was 
administered via the duodenal tube, and the recovery of radio-isotope in the lymph quantitated with time. No differences in 
the appearance of label for either triolein (triglyceride absorption) or cholesterol was observed between WT, HET or HMZ F2 
rats.
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the hypertension phenotype, these should segregate inde-
pendently of the STSL  locus (except for one QTL for
hypertension identified in the GH × BN experiment, but
not reported for crosses involving SHR). Secondly, the lev-
els of plant sterols we employed in our dietary studies are
considerably less than used by others. In almost all of the
studies reported where the exact amount of plant sterols
were reported, these have been almost 10-fold or more
higher than those used in our current study. Our justifica-
tion for not using such large quantities is that it is unlikely
such intakes reflect amounts that would be normally con-
sumed and thus may not be 'physiological'. Thirdly, the
blood pressure measurements were undertaken in ani-
mals fed plain drinking water and in all of the reported
studies where hypertension was monitored, supplementa-
tion with a high salt intake (in water, diet or both) has
been used. Finally, the majority of studies using higher
plant sterols also used increase plant oils as well and the
effect of these on altering the phenotype is not easy to
discern.
We are aware of the limitations of the tail-cuff technique
for blood pressure determinations and subtle, but signifi-
cant differences, in blood pressure may have been masked
by the use of this technique. Our data indicate that
variations at the STSL locus may not be responsible for
major effects in contributing to blood pressure. Any subtle
effects will need to be explored in rat strains that are con-
genic for Gly583Cys on either the SHR or SD
backgrounds.
Although the Gly583Cys change affects an amino acid res-
idue that is conserved from Fugu to Man in Abcg5, this
amino acid substitution is a relatively conservative
change, with no both amino acids being aliphatic and
small. To delineate possible mechanisms by which this
genetic change altered dietary sterol trafficking, we com-
pared intestinal absorption for cholesterol and triglycer-
ide, using lymphatic duct cannulation studies. These
showed that neither cholesterol absorption, nor triglycer-
ide absorption (digestion, uptake, re-synthesis and secre-
tion) were affected by this change. Note that patients with
sitosterolemia, mutated in Abcg8, have been reported to
manifest hyper-absorption of cholesterol, as well as plant
sterols [34]. Unfortunately, sitosterol absorption was not
determined at the same time, as these studies were per-
formed by a core (PT, University of Cincinnati) not rou-
tinely using sitosterol. Biliary excretion of cholesterol and
sitosterol was unaffected by the Gly583Cys alterations,
although the homozygous mutant F2 rats showed
increased amounts of plant sterols in their bile. Thus,
although not definitive, this mutation may cause an
Biliary cholesterol and sitosterol concentrations Figure 6
Biliary cholesterol and sitosterol concentrations. Female F2 rats, on a defined sitosterol diet (see text) had their bile 
ducts cannulated and bile collected under gravity and analyzed for cholesterol (panel A) or sitosterol (panel B). No differences 
in the cholesterol content of bile were noted between any of the genotypes. Note that the concentration of cholesterol is 
approximately 50-fold more than sitosterol. Interestingly, the sitosterol concentration in the F2 HMZ rats was increased signif-
icantly by ~ 50% relative to WT and HET rats (panel B).
*BMC Genetics 2005, 6:40 http://www.biomedcentral.com/1471-2156/6/40
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Tail cuff blood pressure in male and female F2 rats with time Figure 7
Tail cuff blood pressure in male and female F2 rats with time. Tail cuff measured blood pressures for male F2 rats 
(panel A) and female F2 rats (panel B) were monitored with time and analyzed by genotype (solid squares, WT; solid diamonds, 
HET and solid triangles, HMZ). No significant differences were noted between any of these genotypes. For comparison, the 
average blood pressures of rats at age 16 weeks for SD and SHR were 127 mm Hg and 197 mm Hg respectively. Additionally, 
female rats at 17 weeks were placed on a defined sitosterol diet and fed 1% NaCl drinking water (see bar, panel B). Neither 
significant increases in blood pressures, nor any differences between the genotypes were observed.
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increase in the intestinal absorption of non-cholesterol
sterols, leading to increased plasma concentrations.
Despite an increase in biliary secretion, a small net
retention may result, accounting for the sitosterolemia. In
this context, it should be pointed out that the levels of
sitosterolemia observed in these rats are considerably
lower than those seen in patients with sitosterolemia.
Future experiments, using congenic mice and lymph duct
cannulation will allow us to examine this hypothesis and
delineate pathophysiology of this missense mutation.
Conclusion
We report here segregation analyses that prove that the
Gly583Cys alteration identified in WKY, SHR and SHRSP
strains is causative for sitosterolemia, that this alteration
may not be a significant contributor to the hypertension
phenotype, and that it may be causing sitosterolemia by
primarily increasing intestinal absorption on non-choles-
terol sterols. Our study also highlights the need to develop
lines congenic for the missense mutation on an SD back-
ground and the wild-type residue on the SHR background
to allow for the study of Abcg5 function on its role in the
diet-induced decrease in longevity in these hypertensive
strains.
Methods
Animal breeding and husbandry
The Animal Care and Use Committee of Medical Univer-
sity of South Carolina approved all animal protocols.
Inbred SHR (SHR/NCrlBR) rats and outbred CD® (SD)
IGS BR rats were purchased from Charles River Laborato-
ries (CRL, Wilmington, MA). Animals were housed 2–3
rats/cage in a temperature-controlled room (22 ± 2°C)
with a 12-hour light/dark cycle and fed Teklad Sterilized
Rodent Diet (W) 8656 (Harlan, Madison, WI) with free
access to water. To produce F1 progeny, (1 male and 1
female) SHR and (1 male and 1 female) SD were cross-
mated and the F1 resultant progeny randomly mated (4
breeding pairs) to produce 103 F2 progeny. All F2 animals
were fed standard rodent chow and had free access to
water. At 17 weeks of age, female rats were fed a high sito-
sterol diet (sitosterol, 300 mg/kg and cholesterol, 150 mg/
kg, Harlan Teklad diet) and their drinking water supple-
mented with 1% Sodium chloride for 6 weeks. Males were
shipped to University of Cincinnati (PT lab) for lymph
duct cannulation.
Blood pressure and body weight measurements
Blood pressure (BP) was measured in the warmed, con-
scious, restrained state by using the photoelectric oscillo-
metric tail-cuff method using a Natsume KN-210 machine
(Natsume Seisakusho Co. Ltd., Japan). Animals were
accustomized to the apparatus for 1 week, before record-
ings were collected. At each time point, at least 10 read-
ings were obtained for each rat and the average of the
readings taken. Body weights were recorded after each BP
measurement. All data were accumulated independent of
the genotype data.
Genotyping
Blood samples were drawn at 14 weeks of age from all
rats. In addition, blood, was obtained at 20 and 24 weeks
from female rats; the plasma was saved at -70°C for sterol
analysis and genomic DNA, isolated from WBC, used for
genotyping by PCR and Hae III digestion as described pre-
viously [27].
Bile collection
Under Isoflurane anesthesia, the bile duct was cannulated
and bile collected for 15 minutes under gravity as
described previously [16].
Sterol analyses
Plasma and bile samples were processed according to the
methods described by Heinemann [36]. Plasma total cho-
lesterol levels were measured by using gas-liquid chroma-
tography (GC), and plant sterol levels determined by GC-
mass spectrometry with 5-cholestane and epicoprostanol
as internal standards, respectively, as described previ-
ously. Total plant sterols included campestanol, campes-
terol, sitostanol and sitosterol. Campestanol and
sitostanol are 5-dihydro derivatives of campesterol and
sitosterol. Sterol analyses and genotype analyses were per-
formed independently and only after completion of both
were results linked.
Intestinal absorption
The intestinal lymph duct was cannulated using a clear
vinyl tubing (o.d., 0.8 mm) according to the method of
Bollman et al. [37]. The second soft silicone tubing (o.d.,
1.6 mm) was installed in the stomach through the fundus
into the duodenum and secured with a purse-string
suture. A purse-string suture (6-0 silk) and cyanoacrylate
glue were used to secure the duodenal infusion tube. The
gastroduodenal and lymph duct tubes were externalized
through the right flank of the rat to allow easy access for
infusion and collection. The skin, abdominal musculature
and peritoneal layers were closed in a single layer (4-0
silk). The rats were kept in restraining cages at an ambient
temperature of 30°C and allowed to recover from the
anesthesia. The next morning, a lipid emulsion contain-
ing 6 µmol of 3H-triolein, 0.78 µmol of 14C-cholesterol,
0.87 µmol of egg phosphatidylcholine, and 5.7 µmol of
sodium taurocholate (19 mM) in 1.5 ml of phosphate-
buffered saline (pH 6.4) was infused at 1.5 ml/h for 6 h.
Lymph was collected 1 h before the lipid infusion (fast-
ing) and then hourly for 6 h. The volume of collected
lymph was measured by weighting. Samples were counted
for 10 min by a liquid scintillation spectrometer (Model
TR 1900 tri-card; Packard).BMC Genetics 2005, 6:40 http://www.biomedcentral.com/1471-2156/6/40
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Statistical analysis
Statistical analysis was performed by program Prism 2.0.
Comparisons of parameters among 3 groups were
analyzed by one-way ANOVA with Newman-Keuls's post-
test and t-test. All data are expressed as mean ± SD.
Abbreviations
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